Literature DB >> 15811747

Evaluation of apparent ectasia of the posterior surface of the cornea after keratorefractive surgery.

Yoshiaki Nawa1, Kozo Masuda, Tetsuo Ueda, Yoshiaki Hara, Hiroshi Uozato.   

Abstract

PURPOSE: To calculate the apparent posterior corneal changes after keratorefractive surgery and reevaluate corneal ectasia displayed by Orbscan (Orbtek).
SETTING: Department of Ophthalmology, Nara Medical University, Nara, Japan.
METHODS: Postoperative:preoperative magnification ratio of the posterior surface of the cornea was calculated in a theoretical eye model.
RESULTS: Assuming the preoperative corneal thickness is 600.00 microm, the preoperative refractive power of the anterior corneal surface is 48.0 diopters (D), the refractive power of the cornea is 1.376, the ablation diameter is 6.0 mm, the postoperative corneal thickness is 480.00 microm, the postoperative refractive power of the anterior corneal surface is 38.0 D, and the posterior surface of the cornea does not change postoperatively, the apparent image of the posterior surface of the cornea becomes 0.778% smaller postoperatively. If the posterior radius of curvature of the cornea is 6.2 mm, it becomes smaller by 48.24 microm. If this change directly affects the difference map, the posterior surface of the cornea moves forward by 48.24 microm.
CONCLUSION: The results correspond to the amount of ectasia in previous reports. This artifact may explain the apparent ectasia detected by Orbscan.

Entities:  

Mesh:

Year:  2005        PMID: 15811747     DOI: 10.1016/j.jcrs.2004.05.050

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  9 in total

Review 1.  Biomechanics and wound healing in the cornea.

Authors:  William J Dupps; Steven E Wilson
Journal:  Exp Eye Res       Date:  2006-05-23       Impact factor: 3.467

2.  Comparison of central corneal thickness measurements by Orbscan II and Pentacam after corneal refractive surgery.

Authors:  Jumpei Matsuda; Osamu Hieda; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

3.  Scheimpflug imaged corneal changes on anterior and posterior surfaces after collagen cross-linking.

Authors:  Ziad Hassan; Laszlo Modis; Eszter Szalai; Andras Berta; Gabor Nemeth
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Long-term evaluation of posterior corneal surface parameters after accelerated corneal cross-linking with a comparison with uncross-linked keratoconic eyes.

Authors:  Pinar Kosekahya; Mine Turkay; Esra Bahadir Camgoz; Mustafa Koc; Mustafa Ilker Toker
Journal:  Int Ophthalmol       Date:  2022-05-27       Impact factor: 2.031

5.  Day to Day Clinically Relevant Corneal Elevation, Thickness, and Curvature Parameters Using the Orbscan II Scanning Slit Topographer and the Pentacam Scheimpflug Imaging Device.

Authors:  Hassan Hashemi; Shiva Mehravaran
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

6.  Posterior corneal curvature assessment after Epi-LASIK for myopia: comparison of Orbscan II and Pentacam imaging.

Authors:  Yong-Soo Byun; So-Hyang Chung; Young-Geun Park; Choun-Ki Joo
Journal:  Korean J Ophthalmol       Date:  2012-01-14

Review 7.  Corneal topography in keratoconus: state of the art.

Authors:  F Cavas-Martínez; E De la Cruz Sánchez; J Nieto Martínez; F J Fernández Cañavate; D G Fernández-Pacheco
Journal:  Eye Vis (Lond)       Date:  2016-02-22

8.  Evaluating the repeatability of corneal elevation through calculating the misalignment between Successive topography measurements during the follow up of LASIK.

Authors:  XiaoBo Zheng; WeiHua Yang; LiFang Huang; JunJie Wang; Si Cao; Brendan Geraghty; YiPing Zhao; QinMei Wang; FangJun Bao; Ahmed Elsheikh
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

9.  Repeatability of corneal parameters with Pentacam after laser in situ keratomileusis.

Authors:  Rajeev Jain; Grewal Dilraj; Satinder Pal Singh Grewal
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.